View clinical trials related to Elevated Intraocular Pressure.
Filter by:This is a pilot, proof of concept study to evaluate the safety and efficacy of ALZ-1101 dosed once daily for 28 days compared to latanoprost 0.005% ophthalmic solution in patients with elevated intraocular pressure not adequately controlled with latanoprost.
Double-masked, randomized, multi-center, placebo-controlled parallel-comparison of AR-12286.